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Abstract
Omega-3 (v3) polyunsaturated fatty acids (PUFA) are major components of brain cells membranes. v3 PUFA-deficient
rodents exhibit severe cognitive impairments (learning, memory) that have been linked to alteration of brain glucose
utilization or to changes in neurotransmission processes. v3 PUFA supplementation has been shown to lower anxiety and
to improve several cognitive parameters in rodents, while very few data are available in primates. In humans, little is known
about the association between anxiety and v3 fatty acids supplementation and data are divergent about their impact on
cognitive functions. Therefore, the development of nutritional studies in non-human primates is needed to disclose whether
a long-term supplementation with long-chain v3 PUFA has an impact on behavioural and cognitive parameters, differently
or not from rodents. We address the hypothesis that v3 PUFA supplementation could lower anxiety and improve cognitive
performances of the Grey Mouse Lemur (Microcebus murinus), a nocturnal Malagasy prosimian primate. Adult male mouse
lemurs were fed for 5 months on a control diet or on a diet supplemented with long-chain v3 PUFA (n=6 per group).
Behavioural, cognitive and motor performances were measured using an open field test to evaluate anxiety, a circular
platform test to evaluate reference spatial memory, a spontaneous locomotor activity monitoring and a sensory-motor test.
v3-supplemented animals exhibited lower anxiety level compared to control animals, what was accompanied by better
performances in a reference spatial memory task (80% of successful trials vs 35% in controls, p,0.05), while the
spontaneous locomotor activity was reduced by 31% in v3-supplemented animals (p,0.001), a parameter that can be
linked with lowered anxiety. The long-term dietary v3 PUFA supplementation positively impacts on anxiety and cognitive
performances in the adult mouse lemur. The supplementation of human food with v3 fatty acids may represent a valuable
dietary strategy to improve behavioural and cognitive functions.
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Introduction
The brain cells membranes of Vertebrates, including
primates, have high concentrations of long-chain polyunsatu-
rated fatty acids (PUFA) of the omega-3 (v3) and omega-6 (v6)
series, mainly docosahexaenoic acid [DHA, 22:6 (n-3)] and
arachidonic acid [AA, 20:4 (n-6)] [1]. The specific accretion of
DHA (the main v3 PUFA in brain cells membranes) during
perinatal development is considered to be essential for the
proper functioning of the mammalian central nervous system.
T h er o l eo fv3 fatty acids has been mainly investigated using the
dietary deficiency model in which animals, mainly rodents, are
deprived of any source of v3 fatty acids during the perinatal
development (‘‘chronic deficiency’’). It has been demonstrated
that decreased content of DHA is accompanied by severe neuro-
sensorial impairments (learning, memory, anxiety) that have
been linked to changes in neurotransmission processes [2].
Conversely to chronic deficiency, few studies investigated the
impact of v3 PUFA supplementation on behavioural and
cognitive functions.
Several studies showed that chronic v3 PUFA deficiency
increased anxiety, particularly when animals were placed in an
anxiogenic environment. v3-deficient mice and rats exhibited
significant signs of anxiety [3,4] more particularly under stressful
conditions [3]. Harauma and Moriguchi [5] recently confirmed
that dietary v3 PUFA deficiency in mice augments chronic mild
stress-induced anxiety. Furthermore, supplementation with v3
PUFA of mice and rats previously raised under an v3P U F A -
deficient diet reduced their level of anxiety while restoring
normal fatty acid composition in most brain regions [6,4].
Confirming the impact of dietary v3P U F Ao na n x i e t y ,t h e
exploratory behaviour in a novel environment (anxiogenic) was
reduced in v3-deficient rats [7] and improved in v3-supple-
mented mice [4]. These outcomes may be related to increased
and lowered anxiety in deficient and supplemented animals,
respectively.
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deficiency has been shown to impair reference spatial memory
in a circular maze (Barnes maze) in rats [8] and mice [9].
Furthermore, studies in rats [10], mice [11] and hamsters [12]
demonstrated that v3 PUFA deficiency led to hyperactivity, and
more particularly to increased spontaneous locomotor activity.
These observations are confirmed by a supplementation study in
which rats raised on a fish oil diet exhibited reduced locomotor
activity compared to controls [13].
Animal studies, more particularly those performed in rodents,
clearly indicate that long chain v3 fatty acids play a role in
behavioural and cognitive functions. The impact of dietary v3
fatty acids on brain functions in non-human primates has been
studied in a much more small number of works. Tsukada et al.
[14] demonstrated that supplementing aged monkeys with DHA
for 1 to 4 weeks (a very short term dietary supplementation) led to
increased regional cerebral blood flow, a parameter closely linked
to neuronal activation. Since v3 PUFA supplementation may be
effective in the treatment of depressive disorder (reviewed in [15])
it was recently proposed that they may also possess anxiolytic
properties [16]. In humans, few data are available from
intervention studies about the association between anxiety and
v3 fatty acids supplementation and data are divergent about the
ability of dietary v3 fatty acids to prevent age-associated cognitive
decline (see [17] for review). Therefore, the development of
nutritional studies in non-human primates is needed to disclose
whether a long-term supplementation with long-chain v3 PUFA
has an impact on behavioural and cognitive parameters,
differently or not from rodents.
Mouse lemur (Microcebus murinus) is a nocturnal prosimian
primate originating from Madagascar with a life expectancy of
8–10 years. The grey mouse lemur presents specific character-
istics that make it a good model to evaluate the effects of long-
term dietary treatments on behavioral and cognitive parameters
in primates. In particular they present a small size and weight
(80 to 120 g), omnivorous dietary habits, and the possibility to
assess their behavioral and cognitive performances with spe-
cific tasks which have been developed and adapted in our
laboratory [18,19].
We compared the effects of a 5 months supplementation with
long-chain v3 fatty acids or with monounsaturated fatty acids (iso-
caloric control diet), on anxiety, cognitive and motor functions in
the adult mouse lemur. Anxiety was specifically assessed using the
open field task. To evaluate cognitive performances, we used the
circular platform task which recruits the hippocampal system-
dependent spatial memory and which is known to be particularly
adapted for the mouse lemur [19,20]. No food reinforcement is
required, thus motivation to achieve this task is independent of
appetite. In addition, spontaneous locomotor activity in non
anxiogenic environment was evaluated. Motor abilities were also
assessed using the Rotarod test to make sure that differences in
physical performances did not interfere with anxiety and cognitive
performances.
In animal studies, dietary treatments with PUFA are mainly
applied during the perinatal period of developpment (more
particularly for studies on brain functions) and very few studies
are performed with dietary interventions at adult age. There is a
particular interest to determine whether dietary PUFA impact on
brain functions at adult age, inasmuch as the mean dietary intakes
of long chain v3 PUFA in adults are below the levels of
recommendation in developped countries [21]. In the present
study we focused on young adult mouse lemur subjected to a level
of intake corresponding to the recommendation for the French
adult population [22].
The aim of the present study was to evaluate the impact of a
long-term dietary supplementation with v3 fatty acids (under the
form of fish oil, naturally rich in long-chain v3 fatty acids) on
behavior, cognition and motor performances in adult primates.
We postulated that fish oil supplementation may improve
behavioral and cognitive parameters which could be of major
importance in the perspective of their use as supplemental
ingredient in human foods.
Materials and Methods
1 Ethics Statement
All experiments were performed in accordance with the
Principles of Laboratory Animal Care (National Institutes of Health
publication 86–23, revised 1985) and the European Communities
Council Directive (86/609/EEC). The Research was conducted
under the authorization nu 91–305 from the ‘‘Direction De ´parte-
mentale des Services Ve ´te ´rinaires de l’Essonne’’ and the Internal
Review Board of the UMR 7179. All the experiments were done
under personal license (authorization number 91–460, issued 5
June, 2009) delivered by the Ministry of Education and Science. In
accordance with the recommendations of the Weatherall report,
‘‘The use of non-human primates in research’’, special attention
was paid to the welfare of animals during this work [23]. All efforts
were made to minimize nociception.
2 Animals and diets
Adult male grey mouse lemurs (Microcebus murinus, Cheirogalei-
dae, primates) were handled during the summer-like long day
length (14:10 h light-darkness) that corresponds to the active phase
of the animals. Twelve animals (6 per diet group) were included at
the age of 2364 months. Animals were raised on fresh fruits and a
laboratory daily-made mixture of cereals, milk and egg. Water and
food were given ad libitum. Animals were randomly assigned to
each experimental group. The v3-supplemented group received
the home-made food supplemented with tuna oil, rich in long-
chain v3 PUFA, while the control group received the food
supplemented for isoenergy with the same volume of olive oil (rich
in monounsaturated fatty acids and poor in v3 fatty acids). In the
tuna oil supplemented group, the intakes of eicosapentaenoic acid
(EPA, 20:5 n-3) and of docosahexaenoic acid (DHA, 22:6 n-3)
represented about 0.06% and 0.3% of total energy, which is
equivalent to the highest level of consumption of French coastal
populations [24] and corresponds to the recommended daily
intake for the French population [22]. These proportions
correspond to a daily intake of 6 mg EPA and 30 mg DHA per
animal. Cognitive and motor tests were performed between the
fifth and the sixth month of supplementation. Body weights were
measured all along the protocol and remained significantly
unchanged with dietary treatments.
3 Lipid analysis
The blood was collected on heparin, centrifuged and the plasma
was stored at 280uC until analysis. Total lipids were extracted
from plasma with chloroform/methanol 2/1 using the method of
Folch. Total plasma phospholipids were isolated by solid phase
liquid chromatography on silica cartridges; sequential elution was
made with chloroform, then with methanol, which contained the
phospholipid fraction [25]. All eluents were dried under nitrogen,
and the phospholipid fractions were transmethylated with 10%
boron trifluoride (Fluka, Sokolab) at 90uC for 20 min [26]. Fatty
acids methyl esters were analyzed by gas chromatograpy [27]; the
fatty acids composition is expressed as a weight percentage
(g/100 g of total fatty acids).
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The circular plastform task apparatus was an adaptation of the
device described by Barnes [28] for mouse lemurs. It consisted of a
white circular platform (diameter, 100 cm) with 12 equally spaced
circular holes (each 5 cm in diameter) located 3 cm from the
perimeter. The platform could be rotated. The maze platform was
placed 60 cm above the floor, and a cardboard nestbox
(10 cm610 cm620 cm) could be inserted and removed beneath
each hole and served as a refuge (goal box). A black, small plywood
box could be slid beneath the non-goal holes to stop the lemurs
from jumping through these holes while permitting head entering.
To prevent the mouse lemur from escaping, the platform was
entirely surrounded with a white wall 25 cm high and covered
with a transparent PlexiglasH ceiling that permitted the mouse
lemurs to see the extra-maze visual cues. The apparatus was
surrounded by a black curtain hung from a square metallic frame
(length of the side, 120 cm) located 110 cm above the floor. The
center of the frame was a one-way mirror to allow observation.
Attached beneath the one-way mirror and along perimeter of the
maze (about 50 cm above the platform) were 24 evenly spaced
2-W lights, illuminating the maze. Between the one-way mirror
and the upper edge of the wall, various objects were attached
along the inner surface of the curtain to serve as visual cues. The
starting box was an open-ended dark cylinder positioned in the
center of the platform. Transparent radial Plexiglas partitions
(25 cm high620 cm long) were placed between the holes to
prevent the strategy used by some mouse lemurs to go directly to
the periphery of the platform and then walk along the wall and
inspect each hole one by one. Consequently, animals had to return
to the center of the platform after each hole inspection.
Testing procedure. Animals were given one session of
habituation and training (day 1) and one session of testing (day
2). Each session included four trials, each of which began with
placement of the animal inside the starting box. After 30 seconds,
the box was lifted to release the animal. For the lemurs, the
objective was to reach the goal box positioned beneath one of the
12 holes, kept constant relative to the cues for all trials. When the
animal entered the goal box, the trial was stopped, and the animal
was allowed to remain in the goal box for 3 minutes. After each
trial, the platform was cleaned and randomly rotated on its central
axis to avoid the use of intra-maze cues, although the position of
the goal box was kept constant relative to the cues.
On day 1, trials 1 and 2 consisted of placing the animal in a
four-walled chamber containing only the opened goal hole (one-
choice test). For trials 3 and 4, the platform comprised six evenly
spaced open holes (six-choices test). These two trials permitted the
animal to explore the maze, observe the visual cues, and further
learn the position of the goal box.
On day 2 (testing day), 12 holes were opened during the four
trials. Performance was assessed based on the time required for the
animal to reach the right exit (expressed in sec) and the number of
errors and visits prior to reaching the goal box. For each group,
the rate of success was also defined as the ratio of successful trials
on the total number of trials during the testing day, expressed
in %.
5 Open field task
This system was an open-field consisting of bright and opaque
PlexiglasH wall (1006100620 cm) and covered with a transparent
PlexiglasH ceiling. Four white lights of 15 W were placed at each
corner of the system. The open field session was recorded by
camera and the data were analyzed after the session, which
rendered unnecessary the presence of an observer in the room
during the test.
Testing procedure. The mouse lemurs were placed in the
open-field for free exploration for 30 min. At the end of the
session, the nestbox of the mouse lemur was placed in a corner
of the open field (the same corner for all animals) to allow him
to return to its nestbox with a minimal stress. Because of
persistent immobility, peripheral tracking and limited
exploration are index of stress and anxiety in mouse lemurs
when placed in a novel environment. We determined three
parameters reflecting the degree of anxiety for each animal:
total distance travelled during the test (expressed in cm), activity
duration during the test (expressed in s) and number crossings of
the central zone.
6 Accelerating rotating rod task
This apparatus allowed quantification of fine motor coordina-
tion and balance by measuring the amount of time that a mouse
lemur could remain standing on a rotating, accelerating rod
(model 7750, Ugo Basile, Italy). The rod was a plastic drum, 5 cm
in diameter, which was machined to provide traction. The
rotational speed of the system could be progressively increased up
to 40 rpm.
Testing procedure. The animal was placed on the rotating
cylinder at 20 rpm. The rod then accelerated steadily until the
end of the test which was reached when the animal fell or gripped
onto the rod during at least three consecutive turns without
stabilizing its balance. Latency to fall or grip on the rod was
recorded for each trial. Animals underwent 5 consecutive trials
and the best performance was recorded. Values were expressed in
seconds.
7 Spontaneous locomotor activity
Animals were housed individually in a laboratory-made
locomotor activity cage with a capacity of 1 m
3 each provided
with nestbox and supports. Spontaneous locomotor activity was
estimated using a system of presence and motion sensors placed
in the cage and the nestbox created by R. Botalla and adapted
to the mouse lemur. Presence sensors (Honeywell – transmitter:
SEP8705003, receiver: SDP8405014) were placed on both sides
of the nest and were continuously recording in order to detect
animal presence in the nest. Two motion sensors (GARDTEC –
Gardscan ‘M’ series infra-red detectors) were placed in the
corners of the cage to detect the spontaneous movements of the
animal. During animal movements the motion sensors recorded
data every two seconds. Data were stored in a computerized
system (developed in the laboratory by R. Botalla). They were
then computed to represent time-course of these movement
patterns using a software filtering ‘‘ACTOCEBE 3.0’’ developed
in language G from National Instruments (software created by
R. Botalla). Based on animal activity, total movements were
averaged over 5 minutes intervals for further analysis and were
expressed in arbitrary unit (a.u.). A particular focus was given to
night locomotor activity, which is the active period of Grey
mouse lemurs. After 48 h of habituation, spontaneous locomo-
tor activity was recorded during 5 consecutive days for each
animal.
8 Statistical analyses
All values are expressed as mean 6 SEM. Unpaired Student’s
T-test analyses were used to assert significant variations between
the control group and the v3-supplemented group in all studied
parameters. Comparisons were considered to differ significantly
with p,0.05. All statistical computations were performed with
Prism 5 for Windows XP (Graphpad software).
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1 Plasma lipids
Quantification of fatty acids in the plasma total phospholipids
(Table 1) demonstrates that tuna oil supplementation significantly
increased the level of v3 fatty acids and compensatorily decreased
that of v6 and monounsaturated fatty acids. Tuna oil supple-
mented animals exhibited a 3-fold increase in v3 fatty acids
compared to controls (from 8.160.9% of total fatty acids in
control to 24.761.1% in supplemented animals, p,0.01;
t=20.48, df=10) while total v6 and monounsaturated fatty acids
concurrently decreased by 42% (p,0.01; t=12.43, df=10) and
31% (p,0.01; t=22.05, df=10) respectively. DHA was notably
increased close by 160% (p,0.01; t=14.72, df=10) when AA was
decreased by 87% (p,0.01; t=9.637, df=10) upon tuna oil
supplementation. The ratio of total v6:total v3 PUFA was equal
to 0.83:1 in tuna oil supplemented animals and to 4.35:1 in olive
oil supplemented group. The saturated fatty acids were not
substantially altered by dietary treatment.
2 Open field task
The total distance travelled during the open field task was
significantly longer (p=0.019; t=2.830 df=10) in animals fed the
tuna oil (362861170 cm) compared to controls (16746967 cm)
(Figure 1A) as was the activity duration (165.8638.2 s for tuna oil
supplemented animals and 79.2638.4 s for control animals,
p=0.015; t=2.916; df=10) (Figure 1B). The number of times
the animals crossed the central zone was not significantly different
(p=0.268; t=1.172, df=10) between tuna oil supplemented
animals (4.062.0) and controls (1.361.1) (Figure 1C).
3 Circular platform task
The success rate in the circular platform task is expressed as the
number of successful trials on the total number of trials during the
testing day (in %, Figure 2A). Animals of the tuna oil group
exhibited 87.565.0% of success in this task compared to
33.3615.4% for animals of the control group (p=0.0078,
t=3.313, df=10). Moreover, the tuna oil supplemented animals
tended to spend less time to exit from the maze compared to
controls (5246106 s vs 9066145 s; p=0.060, t=1.706, df=10)
(Figure 2B), while their exploratory activity (total number of visits)
was increased (6.861.5 vs 3.260.3; p=0.061, t=2.117, df=10)
(Figure 2C), although these differences did not reach the level of
statistical significance.
4 Accelerating rotating rod task
No significant differences were observed for the performances in
the accelerating rotating rod task (Figure 3) between tuna oil
supplemented animals (65.5634.0 s) and controls (49.8637.0 s) in
the time standing on the rotating rod (p=0.761; t=0.3116,
df=10).
5 Spontaneous locomotor activity
Spontaneous night and day locomotor activity was expressed on
the same scale in arbitrary units (figure 4). Tuna oil supplemented
animals exhibited 31% less nocturnal locomotor activity compared
to controls (p,0.001; t=7.619; df=76) whereas both groups had
low and similar day locomotor activity (p=0.673; t=0.4230;
df=112).
Discussion
We investigated the effects of a 5 month long-chain v3 PUFA
supplementation on behavioural, cognitive and locomotor perfor-
mances in adult mouse lemurs. Our results evidence for the first
time in a non-human primate species that v3 PUFA supplemen-
tation lowered anxiety and spontaneous locomotor activity and
concomitantly improved cognitive performances.
Plasma fatty acids from total phospholipids confirmed that
animals receiving the tuna oil-supplemented diet had significantly
higher levels of circulating long chain v3 PUFA (including EPA,
22:5n-3 and DHA) compared to controls. The brain fatty acid
compositions being not accessible without the sacrifice of animals,
plasma fatty acids constitute a proper marker of body fatty acids
composition. Indeed, it has been demonstrated in several mammal
species that an increase in dietary DHA correlates with plasma
DHA content which is in turn predictive of internal organ DHA
status and is also a useful biomarker of brain DHA status during
adulthood [29]. The increased level of v3 PUFA in tuna oil
supplemented animals occurred at the expense of both v6 PUFA
and monounsaturated fatty acids. These changes contributed to
improve the balance between v3 and v6 PUFA in the plasma
phospholipids of tuna oil supplemented animals with a ratio of
v6:v3 of 0.83:1 compared to 4.35:1 in the olive oil group. It is
recommended for human health benefits that the dietary ratio of
v6:v3 fatty acids should be close to 1:1 [30].
v3 PUFA-supplemented animals exhibited increased activity
during the open field task suggesting a reduction of their level of
anxiety. As suggested by Prut and Belzung [31], in this task,
Table 1. Plasma fatty acids from total phospholipids of
control and tuna oil supplemented animals.
Control (n=6) Fish oil (n=6)
Fatty acids
2 g/100 g
1
12:0 0.560.2 1.960.1
16:0 24.860.6 27.260.3*
18:0 16.760.8 14.460.2*
S Saturated 43.3±0.0 45.0±0.6
18:1 n-9 9.060.0 6.060.2*
18:1 n-7 1.860.0 1.360.0
S Monounsaturated 11.6±0.0 8.0±0.3*
18:2 n-6 13.461.4 8.960.7*
20:4 n-6
a 16.360.1 9.661.2*
22:4 n-6 1.560.3 0.260.1
22:5 n-6 1.560.2 0.460.0
S n-6 Polyunsaturated 35.3±0.8 20.5±1.9*
18:3 n-3 0.160.0 0.160.0
20:3 n-3 0.060.0 0.060.0
20:4 n-3 0.160.0 0.160.0
20:5 n-3
b 0.260.0 4.060.6*
22:5 n-3 1.760.3 4.960.8*
22:6 n-3
c 6.060.7 15.560.9*
S n-3 Polyunsaturated 8.1±0.9 24.7±1.1*
1Values are means 6 SEM, n=6.
*indicates significant differences between dietary treatments with p,0.01.
2Minor fatty acids [14:0, 15:0, 17:0, 19:0, 20:0, 22:0, 24:0, 14:1(n-5), 16:1(n-9),
20:1(n-7), 20:1(n-11), 22:1(n-7), 24:1(n-11), 24:1(n-7), 20:3(n-9), and 22:3(n-9)] are
not reported because they represented ,0.3% of total fatty acids.
a20:4 n-6: Arachidonic Acid (AA),
b20:5 n-3: Eicosapentaenoic Acid (EPA),
c22:6 n-3: Docosahexaenoic Acid (DHA).
doi:10.1371/journal.pone.0020491.t001
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themselves increase exploration in the open field but decrease the
stress-induced inhibition of exploration behaviour. However we
did not observe significant changes in the number of crossings of
the central zone, a parameter closely linked to anxiety, suggesting
a moderate anxiolytic effect of long chain v3 PUFA. This
observation is corroborated by the lowered spontaneous locomotor
activity in a familiar environment measured for v3-supplemented
animals. In this test, performed in their breeding room, animals
are habituated during 48 h to their new cage (similar in size and
form to their home-cage) previously to the recording of
spontaneous locomotor activity during 5 consecutive days. In
such conditions, locomotor activity is generally gradually reduced
over the testing as the animals are habituated to the cage
environment [3]. The observation of reduced spontaneous
locomotor activity in animals fed the v3-supplemented diet
corroborates the potential reduced level of anxiety, a parameter
that could facilitate the habituation process, a simple form of
learning [3]. Our finding that tuna oil-supplemented mouse
lemurs exhibited both lower anxiety in the open field task and
better cognitive performances in the Barnes maze also suggests
that the two outcomes may be directly linked. Indeed, the
tendency to higher exploration in the Barnes maze of the tuna oil
supplemented animals (higher number of visits and lower time
spent to find the right exit) may be issued from the lowering of
anxiety, resulting in a higher score in comparison with more
anxious and less exploring animals (trend) of the control group.
The difference of performance between the two groups might
depend more on their anxiety level than on their intrinsic cognitive
capacity. Similar findings have been made in rodents which
exhibited increased level of anxiety upon chronic v3 PUFA
dietary deficiency [6,4], and decreased anxiety upon DHA
supplementation [4]. Therefore, it is possible that lowering of
anxiety underlies better cognitive performances of mouse lemurs
raised on the tuna oil-enriched diet.
Despite the potential link between anxiety and cognitive
performances, we can not exclude that the better performances
in the Barnes maze could result from a direct improvement of
spatial reference memory due to long-chain v3 PUFA supple-
mentation. Indeed, it has been shown that long chain v3 PUFA
play a major role in brain functions and that they are implicated in
numerous physiological mechanisms (reviewed in [32]). Studies in
rodents have notably demonstrated that v3 PUFA-deficient
animals exhibit severe cognitive impairments that have been
linked to changes in neurotransmission processes [33]. The
neurotransmission process being highly dependent on energy
supply, the effects of v3 fatty acids could occur at the primary level
of glucose utilization by neuronal cells. We have previously shown
that v3 PUFA deficiency [34,35] and supplementation [36,37]
play a role in brain glucose utilization in rats, which could underlie
behavioral changes with v3 PUFA dietary treatments. On the
other hand, Tsukada et al. [14] have shown that a short term
dietary DHA supplementation increased the cerebral blood flow of
aged monkeys, a parameter that is susceptible to impact on brain
glucose utilization and thus on neuronal activation. On the basis of
these observations, we may hypothesize that long-chain v3 PUFA
improve cognitive performances in non-human primates through
the enhancing of brain glucose utilization.
Figure 1. Performances in an open field (OF) task. A. Total
distance travelled (cm). B. Activity duration (s). C. Number of times the
animals crossed the central zone. Values are means 6 SEM, n=6 in each
dietary group. Differences were considered significant between control
(CTL) and tuna oil supplemented animals (v3) with p,0.05.
doi:10.1371/journal.pone.0020491.g001
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night spontaneous locomotor activity, which was not accompanied
by significant change of motor performances (no change in the
performances in the rotating rod task). In agreement with the
present data, lowered locomotor activity has been reported in fish
oil-supplemented rats [13]. The present study is the first to
evidence that a long-chain v3 PUFA supplementation lowers
locomotor activity in non-human primates. In humans, low dietary
v3 PUFA and low tissue levels of DHA are associated with
neurodevelopmental disorders, including attention deficit hyper-
activity disorder (ADHD) (reviewed in [15]). Locomotor activity
and v3 PUFA may be linked through changes in monoamine
neurotransmitters systems. Several studies have reported that
dysregulations of the dopamine system occur in v3 deficient rats
[38,13] and in ADHD in humans and animals [39]. One study
performed in Syrian hamsters (a nocturnal species) reported that
v3 PUFA-deficiency caused a chronic locomotor hyperactivity
which was associated with disturbance in melatonin rhythm and
with hyperdopaminergia [12]. It was proposed that lowering of v3
Figure 4. Spontaneous night and day locomotor activity. Data
were recorded during 5 consecutive 24 h periods (expressed in arbitrary
units of locomotor activity). Values are means 6 SEM, n=6 in each
dietary group. Differences were considered significant between control
(CTL) and tuna oil supplemented animals (v3) with p,0.05.
doi:10.1371/journal.pone.0020491.g004
Figure 2. Performances in a circular maze. A. Rate of success,
expressed as the ratio of successful trials on the total number of trials
(%). B. Time before reaching the right exit (s). C. Total number of visits.
Values are means 6 SEM, n=6 in each dietary group. Differences were
considered significant between control (CTL) and tuna oil supplement-
ed animals (v3) with p,0.05.
doi:10.1371/journal.pone.0020491.g002
Figure 3. Performances in an accelerating rotating rod task.
Data are expressed as the time standing on the rotating rod in s. Values
are means 6 SEM, n=6 in each dietary group. Differences were
considered significant between control (CTL) and tuna oil supplement-
ed animals (v3) with p,0.05.
doi:10.1371/journal.pone.0020491.g003
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functioning of the circadian clock, resulting in sleep disturbances
as it is observed in ADHD patients [12]. However, it is noteworthy
that in our study, only night locomotor activity was significantly
changed (active period) without any change in day locomotor
activity (resting period), suggesting that changes occurring in
v3-supplemented animals do not involve sleep and/or melatonin-
related processes. To date, attempts of v3 PUFA supplementation
in order to treat or to lower ADHD symptoms in children have not
been or have been only partly successful [40,41]. Our present
finding that v3 PUFA supplementation lowers the spontaneous
locomotor activity in mouse lemurs renders this species an
adequate primate model to investigate the role of long-chain v3
PUFA in the etiology and/or treatment of hyperactivity disorders.
Our study evidences that dietary v3 fatty acids positively impact
on anxiety and cognitive performances in adult mouse lemurs, a
non-human primate. The observation of decreased anxiety with
v3 PUFA supplementation is of particular interest in the context
of human health. Indeed, even if it exists significant evidence
supporting the potential anxiolytic effect of v3 PUFA in rodents,
there is a lack of studies to demonstrate it, more particularly in
primates, a fortiori in humans [16]. The present observations are
also very encouraging in the context of aging-associated cognitive
decline, in which handling of dietary v3 fatty acids could offer an
efficient strategy for sustaining cognitive functions. Further studies
are in progress to characterize the impact of long chain v3 PUFA
on behavioral and cognitive performances in this species and to
determine whether the effects on cognitive performances are
attributable to direct improvement of neuronal functions and/or
to lowering of anxiety.
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